Related references
Note: Only part of the references are listed.Necroptosis in the Pathophysiology of Disease
Mitri K. Khoury et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
One-hour universal protocol for mouse genotyping
Romain Joubert et al.
MUSCLE & NERVE (2020)
Applying genome-wide CRISPR-Cas9 screens for therapeutic discovery in facioscapulohumeral muscular dystrophy
Angela Lek et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death
Darko Bosnakovski et al.
SCIENCE ADVANCES (2019)
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019
Stephan von Haehling et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy
Alec M. DeSimone et al.
SCIENCE ADVANCES (2019)
Necroptosis: a crucial pathogenic mediator of human disease
Mary E. Choi et al.
JCI INSIGHT (2019)
A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy
Takako Jones et al.
PLOS ONE (2018)
Necroptosis mediates myofibre death in dystrophin-deficient mice
Jennifer E. Morgan et al.
NATURE COMMUNICATIONS (2018)
DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy
Sean C. Shadle et al.
PLOS GENETICS (2017)
p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy
Darko Bosnakovski et al.
DISEASE MODELS & MECHANISMS (2017)
Facioscapulohumeral Muscular Dystrophy
Alec M. DeSimone et al.
COMPREHENSIVE PHYSIOLOGY (2017)
DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients
Petr Dmitriev et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage
Yara Bou Saada et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2016)
Dux4 controls migration of mesenchymal stem cells through the Cxcr4-Sdf1 axis
Petr Dmitriev et al.
ONCOTARGET (2016)
Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: A double-blind randomized controlled clinical trial
Emilie Passerieux et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways
Amanda M. Rickard et al.
HUMAN MOLECULAR GENETICS (2015)
The diverse role of RIP kinases in necroptosis and inflammation
John Silke et al.
NATURE IMMUNOLOGY (2015)
DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles
Maxime Ferreboeuf et al.
HUMAN MOLECULAR GENETICS (2014)
Nuclear protein spreading: implication for pathophysiology of neuromuscular diseases
Maxime Ferreboeuf et al.
HUMAN MOLECULAR GENETICS (2014)
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Tom Vanden Berghe et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Dominant Lethal Pathologies in Male Mice Engineered to Contain an X-Linked DUX4 Transgene
Abhijit Dandapat et al.
CELL REPORTS (2014)
Concepts of tissue injury and cell death in inflammation: a historical perspective
David Wallach et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Positive and negative phosphorylation regulates RIP1-and RIP3-induced programmed necrosis
Thomas McQuade et al.
BIOCHEMICAL JOURNAL (2013)
Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells
Gregory J. Block et al.
HUMAN MOLECULAR GENETICS (2013)
Dysregulation of 4q35-and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy
Natacha Broucqsault et al.
HUMAN MOLECULAR GENETICS (2013)
Generation of Isogenic D4Z4 Contracted and Noncontracted Immortal Muscle Cell Clones from a Mosaic Patient A Cellular Model for FSHD
Yvonne D. Krom et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2
Richard J. L. F. Lemmers et al.
NATURE GENETICS (2012)
DUX4, a Candidate Gene for Facioscapulohumeral Muscular Dystrophy, Causes p53-Dependent Myopathy In Vivo
Lindsay M. Wallace et al.
ANNALS OF NEUROLOGY (2011)
Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene
Lauren Snider et al.
PLOS GENETICS (2010)
RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy
Lauren Snider et al.
HUMAN MOLECULAR GENETICS (2009)
An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies
Darko Bosnakovski et al.
EMBO JOURNAL (2008)
The DUX4 gene at the FSHDIA locus encodes a pro-apoptotic protein
Valeria Kowaljow et al.
NEUROMUSCULAR DISORDERS (2007)
Kinase RIP3 is dispensable for normal NF-KBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4
K Newton et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress
ST Winokur et al.
NEUROMUSCULAR DISORDERS (2003)
Share Paper
